Skip to Content

Kane Biotech Inc KNBIF

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Kane Biotech Inc is a Canada based biotechnology company engaged in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms. The company's human health product is DispersinB and animal health products include bluestem oral care, STRIX NB, and Alosera. In addition, the company also provides technologies for industrial applications such as medical device coating and hard surface disinfectant.

Contact
162-196 Innovation Drive
Winnipeg, MB, R3T 2N2, Canada
T +1 204 453-1301
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Sep 30, 2020
Fiscal Year End Dec 31, 2020
Stock Type
Employees